Philippines - English - FDA (Food And Drug Administration)

getz pharma (phils.), inc.; distributor: getz pharma (phils.), inc. - simvastatin - film-coated tablet - 10 mg

Egypt - English - EDA (Egyptian Drug Authority)

انتركوفا لمستحضرات الصحة البيطرية - tylosin (as tartarate) 100 000 000i.u. eq. to tylosin tartarate 110gm - powder for oral administration

Philippines - English - FDA (Food And Drug Administration)

stallion laboratories pvt. ltd.; importer: ambica international corporation; distributor: getz pharma (phils.), inc. - piperacillin (as sodium)/tazobactam (as sodium) - powder for injection (i.m./i.v.) - 2 g/250 mg - antibiotic - for the treatment of multidrug-resistant gram-negative infections caused by susceptible organisms.

Philippines - English - FDA (Food And Drug Administration)

ambica international trading corp.; distributor: getz pharma (phils.), inc - piperacillin (as sodium)/ tazobactam (as sodium) - powder for injection (im/iv) - 4g/500mg - antibiotic - for the treatment of multidrug-resistant gram-negative infections caused by susceptible organisms.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

getz pharma private limited, pakistan - salbutamol sulphate - inhaler - 100 mcg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

accord healthcare (pty) ltd - #n/a - not indicated - none

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

accord healthcare (pty) ltd - #n/a - not indicated - none

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: ambica international corporation; distributor: 2mg incorporated - cyclophosphamide - powder for injection (iv) - 1 g

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: ambica international corporation; distributor: 2mg incorporated - cyclophosphamide - powder for i.v. injection - 500 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydralazine hydrochloride, quantity: 25 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate; sodium starch glycollate; disodium edetate; purified talc - this product accepted for registration as 'currently supplied' at the time of commencement of the act. variation to pregnancy statement in product information were approved as specified in the letter of 13 august 1992 from dr bijoy varma. indicated for the treatment of drug resistant, moderate to severe, hypertension. this drug is not a first line antihypertensive drug and is better used in combination with other therapy such as a sympatholytic agent and a diuretic. indications as at 28 november 2001 : hypertension (drug resistant, moderate to severe): as supplementary medication for use together with other antihypertensives such as "beta"-blockers and diuretics; the complementary mechanisms of action of such combined therapy enable the drugs to exert their antihypertensive effects at low doses; in addition, unwanted accompanying effects of the individual substances are either partially offset or even cancelled out.